BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Münch S, Habermehl D, Agha A, Belka C, Combs SE, Eckel R, Friess H, Gerbes A, Nüssler NC, Schepp W, Schmid RM, Schmitt W, Schubert-Fritschle G, Weber B, Werner J, Engel J. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Strahlenther Onkol 2018;194:125-35. [PMID: 29071366 DOI: 10.1007/s00066-017-1225-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian S, Jiang R, Patel PR. Examining the use of pre-operative radiation therapy in addition to perioperative chemotherapy: National Cancer Data Base vs. Surveillance, Epidemiology, and End Results. Cancer 2020;126:2037-8. [PMID: 32022253 DOI: 10.1002/cncr.32716] [Reference Citation Analysis]
2 Xiao Q, Li Z, Ji J. Patients with gastroesophageal junction adenocarcinomas of an advanced stage may benefit from perioperative chemoradiotherapy: A validation based on the Surveillance, Epidemiology, and End Results database. Cancer 2020;126:2036-7. [PMID: 32022255 DOI: 10.1002/cncr.32717] [Reference Citation Analysis]
3 Paireder M, Jomrich G, Kristo I, Asari R, Rieder E, Beer A, Ilhan-Mutlu A, Preusser M, Schmid R, Schoppmann SF. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlenther Onkol 2020;196:779-86. [PMID: 32055873 DOI: 10.1007/s00066-020-01594-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Li Z, Li S, Bu Z, Zhang L, Wu X, Shan F, Jia Y, Ji X, Ji J. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma. J Surg Oncol 2018;118:657-63. [PMID: 30196579 DOI: 10.1002/jso.25188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vitz S, Göbel H, Leibl B, Aigner T, Grabenbauer GG. Adenocarcinoma of the oesophagus: neoadjuvant chemoradiation and radical surgery : Long-term results. Strahlenther Onkol 2018;194:1007-16. [PMID: 29872880 DOI: 10.1007/s00066-018-1320-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Rice TW, Lu M, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction. J Thorac Oncol. 2019;14:2164-2175. [PMID: 31442498 DOI: 10.1016/j.jtho.2019.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma N. Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med 2020;9:E3495. [PMID: 33138060 DOI: 10.3390/jcm9113495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kitano T, Aisu Y, Yasukawa D, Hori T. Aggressive Graphic/Surgical R0 Resection and Jejunal Interposition with Preservation of Mesojejunal Autonomic Nerves in Patients with Stage IV Esophagogastric Junction Adenocarcinoma: A Report of 3 Cases. Am J Case Rep. 2019;20:465-473. [PMID: 30952831 DOI: 10.12659/ajcr.913960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Petrelli F, Ghidini M, Barni S, Sgroi G, Passalacqua R, Tomasello G. Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis. Gastric Cancer. 2019;22:245-254. [PMID: 30483986 DOI: 10.1007/s10120-018-0901-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
10 Han J, Wang Z, Liu C. Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis. Future Oncol 2021;17:2257-74. [PMID: 33739165 DOI: 10.2217/fon-2021-0021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]